|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Wang, Michael L.; Jurczak, Wojciech; Jerkeman, Mats; Trotman, Judith; Zinzani, Pier L.; Belada, David; Boccomini, Carola; Flinn, Ian W.; Giri, Pratyush; Goy, Andre; Hamlin, Paul A.; Hermine, Olivier; Hernandez-Rivas, Jose-Angel; Hong, Xiaonan; Kim, Seok Jin; Lewis, David; Mishima, Yuko; Ozcan, Muhit; Perini, Guilherme F.; Pocock, Christopher; Song, Yuqin; Spurgeon, Stephen E.; Storring, John M.; Walewski, Jan; Zhu, Jun; Qin, Rui; Henninger, Todd; Deshpande, Sanjay; Howes, Angela; Le Gouill, Steven und Dreyling, Martin
(2022):
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
In: New England Journal of Medicine, Bd. 386, Nr. 26: S. 2482-2494
Eyre, Toby A.; Shah, Nirav N.; Dreyling, Martin; Jurczak, Wojciech; Wang, Yucai; Cheah, Chan Y.; Song, Yuqin; Gandhi, Mitul; Chay, Christopher; Sharman, Jeff; Andorsky, David J.; Messersmith, Hannah M.; Ruppert, Amy S.; Muthig, Valerie A.; Ito, Rodrigo und Wang, Michael L.
(2022):
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma.
In: Future Oncology, Bd. 18, Nr. 36: S. 3961-3969
Duell, Johannes; Maddocks, Kami J.; Gonzalez-Barca, Eva; Jurczak, Wojciech; Liberati, Anna Marina; de Vos, Sven; Nagy, Zsolt; Obr, Ales; Gaidano, Gianluca; Abrisqueta, Pau; Kalakonda, Nagesh; Andre, Marc; Dreyling, Martin; Menne, Tobias; Tournilhac, Olivier; Augustin, Marinela; Rosenwald, Andreas; Dirnberger-Hertweck, Maren; Weirather, Johannes; Ambarkhane, Sumeet und Salles, Gilles
(2021):
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
In: Haematologica, Bd. 106, Nr. 9: S. 2417-2426
Salles, Gilles; Duell, Johannes; Gonzalez Barca, Eva; Tournilhac, Olivier; Jurczak, Wojciech; Liberati, Anna Marina; Nagy, Zsolt; Obr, Ales; Gaidano, Gianluca; Andre, Marc; Kalakonda, Nagesh; Dreyling, Martin; Weirather, Johannes; Dirnberger-Hertweck, Maren; Ambarkhane, Sumeet; Fingerle-Rowson, Gunter und Maddocks, Kami
(2020):
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.
In: Lancet Oncology, Bd. 21, Nr. 7: S. 978-988
Hess, Georg; Rule, Simon; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Zhou, Wenjiong; Goldberg, Jenna D.; Trambitas, Cristina; Enny, Christopher; Vermeulen, Jessica; Traina, Shana; Chiou, Chiun-Fang; Diels, Joris und Dreyling, Martin
(2017):
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.
In: Leukemia & Lymphoma, Bd. 58, Nr. 12: S. 2824-2832
Martin, Peter; Maddocks, Kami; Leonard, John P.; Ruan, Jia; Goy, Andre; Wagner-Johnston, Nina; Rule, Simon; Advani, Ranjana; Iberri, David; Phillips, Tycel; Spurgeon, Stephen; Kozin, Eliana; Noto, Katherine; Chen, Zhengming; Jurczak, Wojciech; Auer, Rebecca; Chmielowska, Ewa; Stilgenbauer, Stephan; Bloehdorn, Johannes; Portell, Craig; Williams, Michael E.; Dreyling, Martin; Barr, Paul M.; Chen-Kiang, Selina; DiLiberto, Maurizio; Furman, Richard R. und Blum, Kristie A.
(2016):
Postibrutinib outcomes in patients with mantle cell lymphoma.
In: Blood, Bd. 127, Nr. 12: S. 1559-1563
Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Santucci Silva, Rodrigo; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Balasubramanian, Sriram; Bandyopadhyay, Nibedita; Sun, Steven; Vermeulen, Jessica; Rizo, Aleksandra und Rule, Simon
(2016):
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study.
In: Lancet, Bd. 387, Nr. 10020: S. 770-778
Dreyling, Martin; Hoster, Eva; Bea, Silvia; Hartmann, Elena; Horn, Heike; Hutter, Grit; Salaverria, Itziar; Pott, Christiane; Trneny, Marek; Le Gouill, Steven; Cortelazzo, Sergio; Szymczyk, Michal; Jurczak, Wojciech; Shpilberg, Ofer; Ribrag, Vincent und Hermine, Olivier
(2010):
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
In: Leukemia & Lymphoma, Bd. 51, Nr. 9: S. 1612-1622